person · Reporting owner
Nolan Mangini Siobhan
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alight, Inc. / DelawareALIT · Entity 5436 | Director | July 02, 2026 | July 07, 2026 |
| CASTLIGHT HEALTH, INC.CSLT · Entity 130187 | President | February 16, 2020 | February 19, 2020 |
| NGM BIOPHARMACEUTICALS INCNGM · Entity 11997 | President and CFO | March 02, 2023 | March 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alight, Inc. / Delaware
Report date July 02, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 17,153 |
Reported balance
After 2026-07-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-02 · Grant · Acquired 14,025 · Balance 17,153 F1: Represents restricted stock units granted for annual board service, pursuant to the Issuer's 2021 Omnibus Share Plan, which are scheduled to vest on July 2, 2027. F2: Includes restricted stock units scheduled to vest in the future. F3: Securities listed in this filing have been adjusted to reflect a 1-for-20 reverse split of the Issuer's Class A common stock effective as of June 30, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted for annual board service, pursuant to the Issuer's 2021 Omnibus Share Plan, which are scheduled to vest on July 2, 2027.
F2: Includes restricted stock units scheduled to vest in the future.
F3: Securities listed in this filing have been adjusted to reflect a 1-for-20 reverse split of the Issuer's Class A common stock effective as of June 30, 2026.
CASTLIGHT HEALTH, INC.
Report date February 16, 2020 · Filed February 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 438,998 |
Ending reported balance
After 2020-02-18 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2020-02-16 · Exercise / conversion · Acquired 1,875 · Balance 391,765 Row 2 · 2020-02-16 · Exercise / conversion · Acquired 15,625 · Balance 407,390 Row 3 · 2020-02-16 · Exercise / conversion · Acquired 6,250 · Balance 413,640 Row 4 · 2020-02-16 · Exercise / conversion · Acquired 11,250 · Balance 424,890 Row 5 · 2020-02-16 · Exercise / conversion · Acquired 23,063 · Balance 447,953 Row 6 · 2020-02-16 · Exercise / conversion · Acquired 25,862 · Balance 473,815 Row 7 · 2020-02-18 · Sale · Disposed 34,817 · Balance 438,998 F1: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.21 to $1.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-02-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-02-16 · Exercise / conversion · Disposed 1,875 · Balance 0 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 31,250 |
Reported balance
After 2020-02-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-02-16 · Exercise / conversion · Disposed 15,625 · Balance 31,250 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 25,000 |
Reported balance
After 2020-02-16 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-02-16 · Exercise / conversion · Disposed 6,250 · Balance 25,000 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 90,010 |
Reported balance
After 2020-02-16 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-02-16 · Exercise / conversion · Disposed 11,250 · Balance 90,010 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 276,750 |
Reported balance
After 2020-02-16 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-02-16 · Exercise / conversion · Disposed 23,063 · Balance 276,750 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 362,069 |
Reported balance
After 2020-02-16 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-02-16 · Exercise / conversion · Disposed 25,862 · Balance 362,069 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.21 to $1.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
F4: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F5: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F6: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F7: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F8: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F9: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
NGM BIOPHARMACEUTICALS INC
Report date March 02, 2023 · Filed March 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,000 |
Reported balance
After 2023-03-02 transaction · row 1
1 source rowRow 1 · 2023-03-02 · Grant · Acquired 76,000 · Balance 76,000 F1: Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.36 · Expires 2033-03-01 | Direct | 228,000 |
Reported balance
After 2023-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-02 · Grant · Acquired 228,000 · Balance 228,000 F2: The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.36 · Expires 2033-03-01 | Direct | 200,000 |
Reported balance
After 2023-03-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-02 · Grant · Acquired 200,000 · Balance 200,000 F3: 1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027.
F2: The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis.
F3: 1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2017 Filed Aug 17, 2017 20:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-032654 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 20:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-032654 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| May 18, 2017 Filed May 18, 2017 20:56 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 216 | $3.60 | $777.60 |
DisclosureSEC source: 0001140361-17-021441 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,621 F2 · shares: Represents shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| May 17, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 1,756 | $3.66 | $6,419.58 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · nonDerivative · entry 6 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,259 F3 · shares: Represents the aggregate number of shares sold by the Reporting Person on the same day at different prices. All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.4759 to $3.85 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:56 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021441 · doc1.xml · derivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,469 Underlying: Class B Common Stock · 578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on November 17, 2014, the grant of which was previously reported by the Reporting Person on a Form 3. F4 · derivative.exercise_date: 25% of the RSUs vested on November 17, 2015 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F4 · derivative.expiration_date: 25% of the RSUs vested on November 17, 2015 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:56 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 578 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021441 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on November 17, 2014, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · derivative · entry 10 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,625 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F6 · kind: Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 3. F12 · derivative.exercise_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F12 · derivative.expiration_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · derivative · entry 9 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class B Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F11 · derivative.exercise_date: 25% of the RSUs vested on November 16, 2016 and the remainder vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F11 · derivative.expiration_date: 25% of the RSUs vested on November 16, 2016 and the remainder vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · nonDerivative · entry 5 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · nonDerivative · entry 4 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 1,009 | $3.97 | $4,000.79 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · nonDerivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,640 F3 · shares: Represents the aggregate number of shares sold by the Reporting Person on the same day at different prices. All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.85 to $4.10 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · derivative · entry 8 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,875 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F10 · derivative.exercise_date: 25% of the RSUs will vest on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F10 · derivative.expiration_date: 25% of the RSUs will vest on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · derivative · entry 7 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,375 Underlying: Class B common stock · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F9 · derivative.exercise_date: 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F9 · derivative.expiration_date: 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:49 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021261 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 18:03 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantRestricted Stock Units · Derivative | 100,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-011265 · doc1.xml · derivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class B Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F2 · derivative.exercise_date: 25% of the RSUs will vest on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F2 · derivative.expiration_date: 25% of the RSUs will vest on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 21, 2017 Filed Feb 21, 2017 20:18 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 270 | $3.45 | $931.50 |
DisclosureSEC source: 0001140361-17-008435 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,149 F2 · shares: Represents shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| February 17, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 4,646 | $3.71 | $17,218.08 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · nonDerivative · entry 6 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,841 F3 · shares: Represents the aggregate number of shares sold by the Reporting Person on the same day at different prices. All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.55 to $3.80 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 20:18 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008435 · doc1.xml · derivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,047 Underlying: Class B Common Stock · 578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on November 17, 2014, the grant of which was previously reported by the Reporting Person on a Form 3. F4 · derivative.exercise_date: 25% of the RSUs vested on November 17, 2015 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F4 · derivative.expiration_date: 25% of the RSUs vested on November 17, 2015 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 20:18 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 578 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008435 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on November 17, 2014, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 7,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · derivative · entry 10 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Class B Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F6 · kind: Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 3. F12 · derivative.exercise_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F12 · derivative.expiration_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · derivative · entry 9 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Class B Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F11 · derivative.exercise_date: 25% of the RSUs vested on November 16, 2016 and the remainder vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F11 · derivative.expiration_date: 25% of the RSUs vested on November 16, 2016 and the remainder vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · nonDerivative · entry 5 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · nonDerivative · entry 4 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 1,024 | $3.55 | $3,640.22 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · nonDerivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,487 F3 · shares: Represents the aggregate number of shares sold by the Reporting Person on the same day at different prices. All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.50 to $3.625 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · derivative · entry 8 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F10 · derivative.exercise_date: 25% of the RSUs will vest on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F10 · derivative.expiration_date: 25% of the RSUs will vest on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · derivative · entry 7 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Class B common stock · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F9 · derivative.exercise_date: 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F9 · derivative.expiration_date: 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008217 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| November 18, 2016 Filed Nov 18, 2016 17:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 219 | $4.91 | $1,074.39 |
DisclosureSEC source: 0001140361-16-087289 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,011 F2 · shares: All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| November 17, 2016 Filed Nov 17, 2016 20:13 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 3,753 | $4.99 | $18,712.08 |
DisclosureSEC source: 0001140361-16-087145 · doc1.xml · nonDerivative · entry 5 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,651 F3 · shares: Represents the aggregate number of shares sold by the Reporting Person on the same day at different prices. All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $4.85 to $5.025 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 17, 2016 Filed Nov 18, 2016 17:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 579 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087289 · doc1.xml · derivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,625 Underlying: Class B common stock · 579 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on November 17, 2014, the grant of which was previously reported by the Reporting Person on a Form 3. F4 · derivative.exercise_date: 25% of the RSUs vested on November 17, 2015 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F4 · derivative.expiration_date: 25% of the RSUs vested on November 17, 2015 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| November 17, 2016 Filed Nov 18, 2016 17:32 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 579 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087289 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on November 17, 2014, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| November 16, 2016 Filed Nov 17, 2016 20:13 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087145 · doc1.xml · derivative · entry 8 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class B Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F10 · derivative.exercise_date: 25% of the RSUs will vest on November 16, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F10 · derivative.expiration_date: 25% of the RSUs will vest on November 16, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| November 16, 2016 Filed Nov 17, 2016 20:13 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087145 · doc1.xml · nonDerivative · entry 4 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| November 16, 2016 Filed Nov 17, 2016 20:13 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 962 | $4.97 | $4,785.66 |
DisclosureSEC source: 0001140361-16-087145 · doc1.xml · nonDerivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,404 F3 · shares: Represents the aggregate number of shares sold by the Reporting Person on the same day at different prices. All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $4.85 to $5.10 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 20:13 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087145 · doc1.xml · derivative · entry 7 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,625 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F9 · derivative.exercise_date: 25% of the RSUs will vest on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F9 · derivative.expiration_date: 25% of the RSUs will vest on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 20:13 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087145 · doc1.xml · derivative · entry 6 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 Underlying: Class B common stock · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F8 · derivative.exercise_date: 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F8 · derivative.expiration_date: 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 20:13 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087145 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 20:13 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087145 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.